IDYA vs MSFT: Which Stock is Better?
Side-by-side comparison of Ideaya Biosciences Inc and Microsoft Corp in 2026
IDYA
Ideaya Biosciences Inc
$32.18
MSFT
Microsoft Corp
$419.69
Key Metrics Comparison
| Metric | IDYA | MSFT | Winner |
|---|---|---|---|
| Market Cap | $2.84B | N/A | IDYA |
| P/E Ratio | N/A | 25.70 | MSFT |
| EPS (TTM) | $N/A | $16.00 | MSFT |
| Revenue Growth | 0.6% | 0.2% | IDYA |
| Gross Margin | -43.9% | 68.6% | MSFT |
Analyze IDYA
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IDYA or MSFT a better investment?
Comparing IDYA and MSFT: Ideaya Biosciences Inc has a market cap of $2.84B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IDYA and MSFT?
IDYA (Ideaya Biosciences Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IDYA or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IDYA or MSFT?
IDYA has higher revenue growth at 0.6% vs 0.2% for MSFT.
Which company is more profitable: IDYA or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to -43.9% for IDYA.
Which is the larger company: IDYA or MSFT?
Ideaya Biosciences Inc (IDYA) is larger with a market cap of $2.84B compared to N/A for MSFT.
Should I buy IDYA or MSFT in 2026?
Both IDYA and MSFT have investment merit. IDYA trades at $32.18 while MSFT trades at $419.69. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IDYA and MSFT stock?
Key differences: Market Cap ($2.84B vs N/A), P/E Ratio (N/A vs 25.7x), Revenue Growth (0.6% vs 0.2%), Gross Margin (-43.9% vs 68.6%).